BACE1 and Alzheimer disease: Besides, some studies analyzed the value of combined utilization of the platelet APP ratio and APP secretase (ADAM10、BACE1 and PSEN-1) in AD, and found that the combination has a sensitivity of 88.9%, providing its potential application value in AD diagnosis and screening [27].